Multiple Myeloma

MD IQ

Conference Coverage

Five-minute SC injection of daratumumab in RRMM

“The appeal of subcutaneous daratumumab is the 5 minutes it needs for administering, cutting down considerable on ‘chair/clinic’ time.”

Pages